Immediate Impact

1 from Science/Nature 51 standout
Sub-graph 1 of 24

Citing Papers

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants
2023 Standout
Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance
2022 Standout
2 intermediate papers

Works of H. Bogaerts being referenced

Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations
1998
Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants
1996

Author Peers

Author Last Decade Papers Cites
H. Bogaerts 686 597 257 31 884
Luc Hessel 638 333 324 34 1.2k
Rutger M. Schepp 549 171 302 37 895
H.L. Bock 708 338 379 45 1.1k
Sarah Collins 868 395 204 33 1.1k
Bernard Portnoy 426 236 223 51 841
Nicoline van der Maas 696 454 242 62 1.0k
William Meekison 727 575 228 29 914
Eithne MacMahon 585 99 323 39 1.0k
Achim Kaufhold 639 412 443 51 1.1k
Tuija Leino 540 171 388 51 1.0k

All Works

Loading papers...

Rankless by CCL
2026